Small Molecules
28 June 2013
Regulatory Update – GSK receives positive CHMP opinions for Tafinlar (dabrafenib) and Tyverb (lapatinib)28 June 2013
Soligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn’s DiseaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports